Showing results (321-330 of 355) with videos related to
Sort By:
Pageof 36
Neonatology|March 9, 2007
Neonatal ventilation with inhaled nitric oxide vs. ventilatory support without inhaled nitric oxide for infants with severe respiratory failure born at or near term: the INNOVO multicentre randomised controlled trialD Field, D Elbourne, P Hardy, et al.Journal of Medicinal Chemistry|January 28, 2017
Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase-4 (DPP-4), Antagonists of the C-C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol-3 Kinase δ (PI3Kδ) InhibitorsCarolin Schwehm, Barrie Kellam, Aimie E Garces, et al.BMC Musculoskeletal Disorders|September 23, 2017
Knee pain and related health in the community study (KPIC): a cohort study protocolG S Fernandes, A Sarmanova, S Warner, et al.Journal of Chemical Information and Modeling|June 16, 2026
PyMolGen: Database-Driven Molecular Generation of Drug-Like CompoundsBruno N Falcone, Michael J Hutcheon, Jaffer M Zaidi, et al.ACS Medicinal Chemistry Letters|January 17, 2024
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)Sebastian Dekkers, Dehan Comez, Noemi Karsai, et al.International Journal of Pharmaceutics|June 26, 2022
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiolWanshan Feng, Chaolong Qin, Salah Abdelrazig, et al.Thorax|September 13, 2008
Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstructionM P Swanney, G Ruppel, P L Enright, et al.Nutrients|April 13, 2023
Acute Administration of Ojeok-san Ameliorates Pain-like Behaviors in Pre-Clinical Models of Inflammatory Bowel DiseasesEmma A Patton, Patrice Cunningham, Matthew Noneman, et al.Genes and Immunity|October 26, 2007
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populationsG Zhu, K Carlsen, K-H Carlsen, et al.Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonistsStephen Connolly, Lilian Alcaraz, Andrew Bailey, et al.Pageof 36